From: Metabolic control and bone health in adolescents with type 1 diabetes
Spearman correlation coefficient | p value* | Adjusted p value ** | |
---|---|---|---|
Age | 0.24 | 0.08 | |
Lumbar Spine BMD † | -0.12 | 0.37 | 0.63 |
Volumetric Lumbar Spine † (BMAD) | -0.041 | 0.76 | 0.85 |
Femoral neck BMD † | -0.056 | 0.68 | 0.24 |
Total body BMD † | -0.086 | 0.53 | 0.87 |
% Body fat | 0.30 | 0.02 | 0.66 |
IGF-I (ng/ml) | -0.15 | 0.27 | 0.92 |
IGFBP3 (μg/L) | 0.13 | 0.37 | 0.33 |
IGFBP4 (μg/L) | 0.23 | 0.10 | 0.1 |
IGFBP5 (μg/L) | -0.09 | 0.52 | 0.65 |
NTX (nM BCE/mM creat) | -0.36 | 0.01 | 0.73 |
Bone-specific alkaline phosphatase (μg/L) | -0.26 | 0.06 | 0.81 |
Intact PTH (ρg/ml) | -0.28 | 0.04 | 0.2 |
Serum 25-hydroxyvitamin D (ng/ml) | -0.047 | 0.74 | 0.89 |
Serum Calcium (ml/dL) | 0.15 | 0.28 | 0.19 |
Serum Phosphorus (mg/dL) | 0.2 | 0.14 | 0.01 |
Serum creatinine (mg/dL) | -0.27 | 0.04 | 0.007 |
UCa/uCr | 0.27 | 0.047 | 0.05 |
uPhos/uCr | 0.22 | 0.1 | 0.37 |
Average vitamin D intake/day (IU) | -0.09 | 0.67 | 0.55 |
Average calcium intake/day (mg) | -0.13 | 0.55 | 0.42 |